Business Description
![Integrated Diagnostics Holdings PLC Integrated Diagnostics Holdings PLC logo](https://static.gurufocus.com/logos/0C0000AT7D.png?14)
Integrated Diagnostics Holdings PLC
ISIN : JE00BLKGSR75
Description
Integrated Diagnostics Holdings PLC is active in the healthcare sector. It is a fully integrated diagnostics service provider, operating through brands such as Al Borg and Al Mokhtabar in Egypt, as well as Biolab in Jordan and Ultralab and Al Mokhtabar Sudan in Sudan, Echo-Lab in Nigeria; and Biolab KSA in Saudi Arabia. The company specializes in diagnostic tests, ranging from basic tests, such as glucose testing for diabetes, to molecular tests for hepatitis and specialized DNA tests. The company operates in two segments, Contract Segment which generates key revenue, and the Walk-in Segment. It derives a majority of its revenue from services offered in Egypt.
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.76 | |||||
Equity-to-Asset | 0.41 | |||||
Debt-to-Equity | 0.48 | |||||
Debt-to-EBITDA | 1.31 | |||||
Interest Coverage | 5.5 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 3.73 | |||||
Beneish M-Score | -1.71 | |||||
WACC vs ROIC |
Growth Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -7.7 | |||||
3-Year EBITDA Growth Rate | -19 | |||||
3-Year EPS without NRI Growth Rate | -23.6 | |||||
3-Year FCF Growth Rate | -46.9 | |||||
3-Year Book Growth Rate | -15.8 | |||||
Future 3-5Y EPS without NRI Growth Rate | 18.86 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 39.19 | |||||
9-Day RSI | 52.57 | |||||
14-Day RSI | 57.61 | |||||
6-1 Month Momentum % | -6.17 | |||||
12-1 Month Momentum % | -47.83 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.51 | |||||
Quick Ratio | 1.2 | |||||
Cash Ratio | 0.62 | |||||
Days Inventory | 109.79 | |||||
Days Sales Outstanding | 106.52 | |||||
Days Payable | 91.35 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -3.39 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 35.64 | |||||
Operating Margin % | 17.73 | |||||
Net Margin % | 19.15 | |||||
FCF Margin % | 1.28 | |||||
ROE % | 14.28 | |||||
ROA % | 6.33 | |||||
ROIC % | 5.21 | |||||
ROC (Joel Greenblatt) % | 25.51 | |||||
ROCE % | 12.33 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 20.5 | |||||
Forward PE Ratio | 13.43 | |||||
PE Ratio without NRI | 20.5 | |||||
Shiller PE Ratio | 6.73 | |||||
Price-to-Owner-Earnings | 389.5 | |||||
PS Ratio | 4.1 | |||||
PB Ratio | 3.93 | |||||
Price-to-Tangible-Book | 12.98 | |||||
Price-to-Free-Cash-Flow | 389.5 | |||||
Price-to-Operating-Cash-Flow | 55.64 | |||||
EV-to-EBIT | 14.83 | |||||
EV-to-EBITDA | 11.02 | |||||
EV-to-Forward-EBITDA | 4.93 | |||||
EV-to-Revenue | 4.22 | |||||
EV-to-Forward-Revenue | 1.64 | |||||
EV-to-FCF | 330.13 | |||||
Price-to-Projected-FCF | 0.97 | |||||
Price-to-Graham-Number | 2.6 | |||||
Earnings Yield (Greenblatt) % | 6.74 | |||||
FCF Yield % | 0.31 |